Basic Information
ClostraBio, a startup developing drugs that can prevent allergic reactions to food. ClostraBio's scientific team has made significant discoveries highlighting the importance of gut microbiota in modulating food allergy sensitization. The company is committed to gaining a deeper understanding of the role gut microbes play in intestinal barrier function and identifying mechanisms of barrier protection.
ClostraBio
United States of America
less than 15 people
January 01, 2016
information@clostrabio.com

